Cargando…

Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial

Aim: To assess the results of a phase I/IIa open-label dose-escalation clinical trial of 5-day repeated intramuscular administration of pitavastatin-incorporated poly (lactic-co-glycolic acid) nanoparticles (NK-104-NP) in patients with chronic limb threatening ischemia (CLTI). Methods: NK-104-NP was...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matsumoto, Takuya, Yoshino, Shinichiro, Furuyama, Tadashi, Morisaki, Koichi, Nakano, Kaku, Koga, Jun-ichiro, Maehara, Yoshihiko, Komori, Kimihiro, Mori, Masaki, Egashira, Kensuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135659/ https://www.ncbi.nlm.nih.gov/pubmed/33907060 http://dx.doi.org/10.5551/jat.58941

Ejemplares similares

Therapeutic Arteriogenesis/Angiogenesis for Peripheral Arterial Disease by Nanoparticle-Mediated Delivery of Pitavastatin into Vascular Endothelial Cells
por: Matsumoto, Takuya, et al.
Publicado: (2020)

A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model
por: Ichimura, Kenzo, et al.
Publicado: (2016)

Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apoe (−/−) Mice
por: Katsuki, Shunsuke, et al.
Publicado: (2022)

A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K/Akt Pathway and Anti-Inflammation in a Rat Model
por: Nagaoka, Kazuhiro, et al.
Publicado: (2015)

Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017)

Internal Iliac Artery Aneurysm Ruptures with No Visualized Endoleak 2 Years after Endovascular Repair
por: Harada, Ayumi, et al.
Publicado: (2022)

Cystic Arterial Disease Located Only in the Media of the Popliteal Artery: A Case Report
por: Yoshino, Shinichiro, et al.
Publicado: (2019)

Platelet Count Recovery after Endovascular Aneurysm Repair for Abdominal Aortic Aneurysm
por: Inoue, Kentaro, et al.
Publicado: (2021)

BubR1 Insufficiency Results in Decreased Macrophage Proliferation and Attenuated Atherogenesis in Apolipoprotein E‐Deficient Mice
por: Tanaka, Shinichi, et al.
Publicado: (2016)

True brachial artery aneurysm after arteriovenous fistula closure following renal transplantation: a case report and literature review
por: Toyota, Satoshi, et al.
Publicado: (2019)

Nanoparticle‐Mediated Simultaneous Targeting of Mitochondrial Injury and Inflammation Attenuates Myocardial Ischemia‐Reperfusion Injury
por: Ikeda, Gentaro, et al.
Publicado: (2021)

Simultaneous targeting of mitochondria and monocytes enhances neuroprotection against ischemia–reperfusion injury
por: Okahara, Arihide, et al.
Publicado: (2020)

Nanoparticle-Mediated Delivery of Irbesartan Induces Cardioprotection from Myocardial Ischemia-Reperfusion Injury by Antagonizing Monocyte-Mediated Inflammation
por: Nakano, Yasuhiro, et al.
Publicado: (2016)

Interleukin‐38 suppresses abdominal aortic aneurysm formation in mice by regulating macrophages in an IL1RL2‐p38 pathway‐dependent manner
por: Kurose, Shun, et al.
Publicado: (2023)

Nanoparticle‐Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia‐Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction
por: Ishikita, Ayako, et al.
Publicado: (2016)

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Pitavastatin Reduces Inflammation in Atherosclerotic Plaques in Apolipoprotein E-Deficient Mice with Late Stage Renal Disease
por: Shibasaki, Manabu, et al.
Publicado: (2015)

Ezetimibe reduced hepatic steatosis induced by dietary oxysterols in nonhuman primates
por: Deushi, Michiyo, et al.
Publicado: (2016)

Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010)

Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits
por: de Almeida, Eros Antonio, et al.
Publicado: (2014)

Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
por: Tsujita, Kenichi, et al.
Publicado: (2023)

Thoracic endovascular aortic repair for complicated chronic type B aortic dissection in a patient on hemodialysis with recurrent ischemic colitis
por: Miyazaki, Yuko, et al.
Publicado: (2016)

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013)

Pitavastatin suppressed liver cancer cells in vitro and in vivo
por: You, He-Yi, et al.
Publicado: (2016)

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020)

Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
por: Jeong, In-Kyung, et al.
Publicado: (2020)

Nanoparticle-Mediated Targeting of Cyclosporine A Enhances Cardioprotection Against Ischemia-Reperfusion Injury Through Inhibition of Mitochondrial Permeability Transition Pore Opening
por: Ikeda, Gentaro, et al.
Publicado: (2016)

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
por: Nomura, Shosaku, et al.
Publicado: (2012)

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
por: Chamberlin, Kevin W, et al.
Publicado: (2015)

Chest pain as a possible side effect of pitavastatin (Livalo)
por: AlZahrani, Nada R., et al.
Publicado: (2019)

Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues
por: Makuc, Damjan, et al.
Publicado: (2013)

Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
por: Fujimoto, Takashi, et al.
Publicado: (2021)

Pitavastatin Induces Cancer Cell Apoptosis by Blocking Autophagy Flux
por: Tilija Pun, Nirmala, et al.
Publicado: (2022)

BubR1 Insufficiency Impairs Liver Regeneration in Aged Mice after Hepatectomy through Intercalated Disc Abnormality
por: Ikawa-Yoshida, Ayae, et al.
Publicado: (2016)

Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia
por: Yamasaki, Tomohiro, et al.
Publicado: (2014)

Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage
por: Ibuki, Chikao, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f8rt13da4tn1do96dfatqgo4up